Dimensional Fund Advisors LP Has $371,000 Stake in Enzo Biochem, Inc. (NYSE:ENZ)

Dimensional Fund Advisors LP trimmed its holdings in shares of Enzo Biochem, Inc. (NYSE:ENZ) by 48.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 340,333 shares of the medical research company’s stock after selling 315,462 shares during the period. Dimensional Fund Advisors LP owned 0.66% of Enzo Biochem worth $371,000 as of its most recent SEC filing.

Enzo Biochem Stock Performance

Shares of ENZ opened at $1.14 on Tuesday. The business’s fifty day moving average price is $1.12 and its two-hundred day moving average price is $1.12. Enzo Biochem, Inc. has a 52 week low of $0.99 and a 52 week high of $1.50.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on Enzo Biochem in a research report on Monday. They issued a “hold” rating on the stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.